Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

GHRP-6

Growth Hormone Releasing Peptide-6, Growth hormone-releasing hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

Quick Stats
Studies 702
Trials 0
Score 3
2013 pubmed

Multiple signaling pathways mediate ghrelin-induced proliferation of hippocampal neural stem cells.

Chung. Hyunju H; Li. Endan E; Kim. Yumi Y; Kim. Sehee S; Park. Seungjoon S

Key Findings

  • Ghrelin binds to its receptor (GHS‑R1a) on hippocampal neural stem cells and increases their proliferation.
  • The proliferative effect is blocked by the GHS‑R1a antagonist d‑Lys‑3‑GHRP‑6, confirming receptor‑mediated action.
  • Ghrelin activates multiple signaling pathways (ERK1/2, PI3K/Akt, mTOR/p70S6K, and STAT3) that are necessary for the cell‑division response.

Practical Outcomes

  • For biohackers, the data suggest that ghrelin‑mimicking peptides like GHRP‑6 could potentially support brain health by promoting stem‑cell growth, but the evidence is limited to rat cells in vitro. More human and clinical research is needed before incorporating GHRP‑6 specifically for neurogenesis or cognitive enhancement.

Summary

The study shows that ghrelin, the hormone that GHRP‑6 mimics, can make rat brain stem cells in the hippocampus multiply more, and it does this by turning on several cell‑growth pathways. Blocking the ghrelin receptor stops this effect, and the peptide doesn’t seem to push the cells to become neurons, just to divide. While the work is done in a dish with rat cells, it hints that ghrelin‑like compounds might boost brain cell renewal.

Abstract

Ghrelin, an endogenous ligand for the GH secretagogue receptor (GHS-R) receptor 1a (GHS-R1a), has been implicated in several physiologic processes involving the hippocampus. The aim of this study was to investigate the molecular mechanisms of ghrelin-stimulated neurogenesis using cultured adult rat hippocampal neural stem cells (NSCs). The expression of GHS-R1a was detected in hippocampal NSCs, as assessed by western blot analysis and immunocytochemistry. Ghrelin treatment increased the proliferation of cultured hippocampal NSCs assessed by BrdU incorporation. The exposure of cells to the receptor-specific antagonist d-Lys-3-GHRP-6 abolished the proliferative effect of ghrelin. By contrast, ghrelin showed no significant effect on cell differentiation. The expression of GHS-R1a was significantly increased by ghrelin treatment. The analysis of signaling pathways showed that ghrelin caused rapid activation of ERK1/2 and Akt, which were blocked by the GHS-R1a antagonist. In addition, ghrelin stimulated the phosphorylation of Akt downstream effectors, such as glycogen synthase kinase (GSK)-3β, mammalian target of rapamycin (mTOR), and p70(S6K). The activation of STAT3 was also caused by ghrelin treatment. Furthermore, pretreatment of cells with specific inhibitors of MEK/ERK1/2, phosphatidylinositol-3-kinase (PI3K)/Akt, mTOR, and Jak2/STAT3 attenuated ghrelin-induced cell proliferation. Taken together, our results support a role for ghrelin in adult hippocampal neurogenesis and suggest the involvement of the ERK1/2, PI3K/Akt, and STAT3 signaling pathways in the mediation of the actions of ghrelin on neurogenesis. Our data also suggest that PI3K/Akt-mediated inactivation of GSK-3β and activation of mTOR/p70(S6K) contribute to the proliferative effect of ghrelin.

Study Information

Provider

pubmed

Year

2013

Date

2013-06-01T00:00:00.000Z

DOI

10.1530/joe-13-0045